Increased cellular expression of matrix proteins that regulate mineralization is associated with calcification of native human and porcine xenograft bioprosthetic heart valves
about
Ectopic calcification: gathering hard facts about soft tissue mineralizationOsteopontin inhibits mineral deposition and promotes regression of ectopic calcificationMolecular and cellular aspects of calcific aortic valve diseaseCalciphylaxis: emerging concepts in prevention, diagnosis, and treatmentValvular aortic stenosis: a proteomic insightOsteopontin: a key cytokine in cell-mediated and granulomatous inflammation.Osteopontin--a molecule for all seasons.Impact of recipient-related factors on structural dysfunction of xenoaortic bioprosthetic heart valvesMatricellular proteins in cardiac adaptation and disease.Role for circulating osteogenic precursor cells in aortic valvular disease.Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosisOsteogenic regulation of vascular calcification: an early perspective.Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivoDegenerative valve disease and bioprostheses: risk assessment, predictive diagnosis, personalised treatmentsThe association of hypertension and aortic valve sclerosis.Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo.Is the degeneration of aortic valve bioprostheses similar to that of native aortic valves? Insights into valvular pathology.Pathophysiology of valvular heart disease.The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology.Tissue-engineered heart valve prostheses: 'state of the heart'.Genetic variation and atherosclerosis.Efficacy of simvastatin treatment of valvular interstitial cells varies with the extracellular environment.Serum levels of undercarboxylated osteocalcin are related to cardiovascular risk factors in patients with type 2 diabetes mellitus and healthy subjects.Correlates of valvular ossification in patients with aortic valve stenosis.Liquefaction necrosis of mitral annular calcification (LNMAC): review of pathology, prevalence, imaging and management: proposed diagnostic imaging criteria with detailed multi-modality and MRI image characterization.MicroRNA-449c-5p inhibits osteogenic differentiation of human VICs through Smad4-mediated pathway.The angiotensin II type 1 receptor blocker losartan attenuates bioprosthetic valve leaflet calcification in a rabbit intravascular implant model.Inflammatory biomarker kinetics after mechanical and bioprosthetic valve replacement.Reduced leaflet stress in the stentless quadrileaflet mitral valve: a finite element model.HIF-1α and VEGF: Immunohistochemical Profile and Possible Function in Human Aortic Valve Stenosis.Regulation of valvular interstitial cell phenotype and function by hyaluronic acid in 2-D and 3-D culture environmentsRegulation of valvular interstitial cell calcification by components of the extracellular matrix.
P2860
Q24671681-D49CC741-1D49-440C-AB97-BC817BD5A4C3Q24684936-996C49C9-5DE9-40C4-8ED0-0209953F03FEQ27026105-1A94617D-21CA-46A1-B2D7-517BB0EBD391Q28213077-2DCCE6F1-DAC8-493B-B51F-ABFF2D4266C8Q33908760-C3D30849-3759-4AEF-934E-EC81193DF0B8Q34216288-C3C9A895-DE94-4631-88B5-15F64E3284D7Q34522057-0C75C230-0543-4655-AC32-FCF4614026DFQ35174201-F45F8BFF-5462-4BBA-9B02-0278CC697DE3Q35542423-59901E33-16EA-42E5-BFCB-875F2E09629CQ35563353-71B58329-E0BE-4323-9A26-8329DEBEC297Q35746579-6E08C579-AC12-41D9-AFE7-FCA44F7224B0Q35753562-E9AE5CB1-C082-4615-B558-A34A697B3F6DQ35763795-391B8415-0B30-4BFA-A27D-762D6882FBD0Q36117837-7441305E-AF7C-4D1B-8F6E-236644171ABAQ36300823-62C785A2-33DF-4E0C-B096-78D9D4E33403Q36371196-7D0E876A-EA74-4595-B260-CDC60B6A6170Q36546306-55F279AF-E7DE-4759-AE62-319A4A0A2609Q36742337-19CE6DB8-9011-448D-A105-AF4481A47B84Q36933045-4A77961B-C475-48F5-BADE-DA25C2FC8AECQ37156681-6447CE93-30BE-41A7-AFB6-96A577D6BAB5Q37172163-725F7B9D-0B82-4712-A8A6-7E3D7A64E052Q37239791-164645A5-BD9F-4415-855C-040DC4EF237AQ37587460-28FBBED4-86F9-43A7-BB68-F81E9B7F1DDCQ37700421-FE87CF79-0D0C-4A42-BB2F-C5E45FF8165EQ37921645-9E99DB91-64C9-4288-A141-E1282F34EB6BQ38617922-89B34376-8577-4DC1-A5E6-7A8125F7F2BDQ40645911-7E097296-24E0-405B-940D-A660C18DA7A3Q41019040-150CE780-CFEC-4994-B540-D08157913A1CQ41291850-9894EA37-2D22-4DB7-BC68-21CD36433E25Q41608987-49983358-3AD8-4D4D-B52B-373DD74A3EF4Q42571855-8FC1F46A-EDCF-4E9E-B963-8644A6D3E9E9Q43003872-7D489160-94F1-4BF7-8E5E-1950E45EA6A3
P2860
Increased cellular expression of matrix proteins that regulate mineralization is associated with calcification of native human and porcine xenograft bioprosthetic heart valves
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Increased cellular expression ...... aft bioprosthetic heart valves
@en
type
label
Increased cellular expression ...... aft bioprosthetic heart valves
@en
prefLabel
Increased cellular expression ...... aft bioprosthetic heart valves
@en
P2093
P2860
P356
P1476
Increased cellular expression ...... aft bioprosthetic heart valves
@en
P2093
C M Johnson
L A Fitzpatrick
P B Maercklein
P J Harrity
S S Srivatsa
W D Edwards
P2860
P304
P356
10.1172/JCI119265
P407
P577
1997-03-01T00:00:00Z